These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27416004)

  • 1. Intracystic bleomycin for cystic craniopharyngiomas in children.
    Zhang S; Fang Y; Cai BW; Xu JG; You C
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008890. PubMed ID: 27416004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracystic bleomycin for cystic craniopharyngiomas in children.
    Zheng J; Fang Y; Cai BW; Zhang H; Liu W; Wu B; Xu JG; You C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008890. PubMed ID: 25233847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracystic bleomycin for cystic craniopharyngiomas in children.
    Fang Y; Cai BW; Zhang H; Liu W; Wu B; Xu JG; You C
    Cochrane Database Syst Rev; 2012 Apr; (4):CD008890. PubMed ID: 22513968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review).
    Liu W; Fang Y; Cai B; Xu J; You C; Zhang H
    Neurosurgery; 2012 Nov; 71(5):909-15. PubMed ID: 22902333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for children with medulloblastoma.
    Michiels EM; Schouten-Van Meeteren AY; Doz F; Janssens GO; van Dalen EC
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006678. PubMed ID: 25879092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
    Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children.
    Hader WJ; Steinbok P; Hukin J; Fryer C
    Pediatr Neurosurg; 2000 Oct; 33(4):211-8. PubMed ID: 11124639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
    van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
    Yalçin B; Kremer LC; Caron HN; van Dalen EC
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006301. PubMed ID: 23970444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.
    de Baat EC; Mulder RL; Armenian S; Feijen EA; Grotenhuis H; Hudson MM; Mavinkurve-Groothuis AM; Kremer LC; van Dalen EC
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014638. PubMed ID: 36162822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD009219. PubMed ID: 27669661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.